Theleme Partners LLP Moderna, Inc. Transaction History

Theleme Partners LLP

$1.46 Billion
Q2 2025

A detailed history of Theleme Partners LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Theleme Partners LLP holds 7,868,810 shares of MRNA stock, worth $202 Million. This represents 14.86% of its overall portfolio holdings.

Number of Shares

7,868,810

Previous 7,242,390 8.65%

Holding current value

$202 Million

Previous $205 Million 5.74%

% of portfolio

14.86%

Previous 17.26%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$23.65 - $28.54 $14.8 Million - $17.9 Million	626,420 Added 8.65%	7,868,810 $217 Million
Q1 2025 May 14, 2025	SELL	$28.35 - $47.53 $1.83 Million - $3.06 Million	-64,471 Reduced 0.88%	7,242,390 $205 Million
Q4 2024 Feb 13, 2025	BUY	$36.85 - $63.93 $2.95 Million - $5.11 Million	80,000 Added 1.11%	7,306,861 $304 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $9.61 Million - $15.8 Million	-94,936 Reduced 1.3%	7,226,861 $858 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $2.36 Million - $3.19 Million	-27,659 Reduced 0.38%	7,321,797 $780 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $31.4 Million - $47.2 Million	451,844 Added 6.55%	7,349,456 $731 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $62.8 Million - $82.4 Million	651,113 Added 10.42%	6,897,612 $712 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $15.9 Million - $21.5 Million	134,065 Added 2.19%	6,246,499 $759 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $34.4 Million - $50 Million	253,576 Added 4.33%	6,112,434 $939 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $17.2 Million - $30.6 Million	-145,548 Reduced 2.42%	5,858,858 $1.05 Billion
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $41.3 Million - $68 Million	-350,000 Reduced 5.51%	6,004,406 $710 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $2.05 Million - $3.08 Million	17,466 Added 0.28%	6,354,406 $908 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $166 Million - $309 Million	1,314,766 Added 26.18%	6,336,940 $1.09 Billion
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $241 Million - $393 Million	1,065,100 Added 26.92%	5,022,174 $1.28 Billion
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $469 Million - $1.02 Billion	-2,114,982 Reduced 34.83%	3,957,074 $1.52 Billion
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $29.9 Million - $54 Million	-230,000 Reduced 3.65%	6,072,056 $1.43 Billion
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $105 Million - $178 Million	958,358 Added 17.93%	6,302,056 $825 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $152 Million - $392 Million	-2,309,280 Reduced 30.17%	5,343,698 $558 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $48.6 Million - $84.8 Million	-893,941 Reduced 10.46%	7,652,978 $541 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $11.4 Million - $30.7 Million	-384,000 Reduced 4.3%	8,546,919 $549 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $44.3 Million - $78.7 Million	2,490,645 Added 38.67%	8,930,919 $267 Million
Q4 2019 Feb 13, 2020	BUY	$13.93 - $21.28 $89.7 Million - $137 Million	6,440,274 New	6,440,274 $126 Million
Q3 2019 Nov 13, 2019	BUY	$12.26 - $18.07 $21.5 Million - $31.8 Million	1,757,647 Added 45.6%	5,612,445 $89.4 Million
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $22.4 Million - $46.3 Million	-1,632,513 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $7.26 Million - $11.9 Million	502,513 Added 44.47%	1,632,513 $33.2 Million
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $15.3 Million - $21.2 Million	1,130,000 New	1,130,000 $17.3 Million

Others Institutions Holding MRNA

# of Institutions

858

Shares Held

267M

Call Options Held

28.5M

Put Options Held

34.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Theleme Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Theleme Partners LLP with notifications on news.

Account

Theleme Partners LLP Moderna, Inc. Transaction History